NRBO logo

NeuroBo Pharmaceuticals (NRBO) Cash From Operations

Annual CFO

-$10.80 M
+$913.00 K+7.80%

December 31, 2023

Summary

Performance

1-Year Change

+7.8%

3-Year Change

-0.33%

5-Year Change

+25.27%

15-Year Change

+59.86%

NRBO Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

59.24%
NRBO annual cash flow from operations is higher than 59.24% of companies in Healthcare sector

High & Low

All-time High

-$195.00 K

3-Year Low

-$15.13 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
NRBO previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

May 9, 2025
NRBO next annual earnings announcement is scheduled for May 9, 2025

OtherNRBOcash flowmetrics:

Annual CFI

-$50.00 K
NRBO annual cash flow from investing activities is -$50.00 thousand

Annual CFF

-$80.00 K
NRBO annual cash flow from financing activities is -$80.00 thousand

Annual FCF

-$10.85 M
NRBO annual free cash flow is -$10.85 million

Annual CAPEX

-
NRBO annual capital expenditures value is unknown

Quarterly CFO

-$5.59 M
+$1.66 M+22.92%

September 30, 2024

Summary

Performance

3-Month Change

+22.92%

1-Year Change

-64.72%

3-Year Change

-122.94%

5-Year Change

-67.09%

NRBO Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

43.65%
NRBO quarterly cash flow from operations is higher than 43.65% of companies in Healthcare sector

High & Low

All-time High

$3.35 M
NRBO quarterly cash flow from operations is currently -266.99% below its historical high of $3.35 million

3-Year Low

-$7.25 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
NRBO previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

May 9, 2025
NRBO next earnings announcement is scheduled for May 9, 2025

OtherNRBOcash flowmetrics:

Quarterly CFI

$0.00
NRBO quarterly cash flow from investing activities is $0.00

Quarterly CFF

-$676.00 K
NRBO quarterly cash flow from financing activities is -$676.00 thousand

Quarterly FCF

-$5.59 M
NRBO quarterly free cash flow is -$5.59 million

Quarterly CAPEX

-
NRBO quarterly capital expenditures value is unknown

TTM CFO

-$22.68 M
-$2.77 M-13.94%

September 30, 2024

Summary

Performance

3-Month Change

-13.94%

1-Year Change

-109.97%

3-Year Change

-55.49%

5-Year Change

-222.13%

NRBO TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

43.04%
NRBO TTM cash flow from operations is higher than 43.04% of companies in Healthcare sector

High & Low

All-time High

-$620.00 K

3-Year Low

-$22.68 M
NRBO TTM cash flow from operations is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
NRBO previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

May 9, 2025
NRBO next earnings announcement is scheduled for May 9, 2025

OtherNRBOcash flowmetrics:

TTM CFI

-$17.00 K
NRBO TTM cash flow from investing activities is -$17.00 thousand

TTM CFF

$18.52 M
NRBO TTM cash flow from financing activities is $18.52 million

TTM FCF

-$22.69 M
NRBO TTM free cash flow is -$22.69 million

TTM CAPEX

-
NRBO TTM capital expenditures value is unknown

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

NRBO Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+7.8%-64.7%-110.0%
3 y3 years-0.3%-122.9%-55.5%
5 y5 years+25.3%-67.1%-222.1%

NRBO Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+28.6%-209.3%+22.9%-158.9%at low
5 y5-year-53.4%+28.6%-337.3%+22.9%-222.1%at low
alltimeall time-5437.9%+59.9%-267.0%+23.4%-3557.3%+18.8%

NeuroBo Pharmaceuticals Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
-$5.59 M(-22.9%)
-$22.68 M(+13.9%)
Jun 2024
-
-$7.25 M(+12.6%)
-$19.90 M(+35.4%)
Mar 2024
-
-$6.44 M(+89.9%)
-$14.69 M(+36.1%)
Dec 2023
-$10.80 M(-7.8%)
-$3.39 M(+20.6%)
-$10.80 M(+17.2%)
Sep 2023
-
-$2.81 M(+37.6%)
-$9.21 M(+5.2%)
Jun 2023
-
-$2.04 M(-19.7%)
-$8.76 M(-7.1%)
Mar 2023
-
-$2.55 M(+41.0%)
-$9.43 M(-19.5%)
Dec 2022
-$11.71 M(-22.6%)
-$1.81 M(-23.4%)
-$11.71 M(-8.5%)
Sep 2022
-
-$2.36 M(-13.2%)
-$12.80 M(-1.1%)
Jun 2022
-
-$2.72 M(-43.7%)
-$12.95 M(-6.3%)
Mar 2022
-
-$4.83 M(+66.6%)
-$13.82 M(-8.7%)
Dec 2021
-$15.13 M(+40.6%)
-$2.90 M(+15.6%)
-$15.13 M(+3.8%)
Sep 2021
-
-$2.51 M(-30.1%)
-$14.58 M(+3.9%)
Jun 2021
-
-$3.59 M(-41.6%)
-$14.03 M(+9.9%)
Mar 2021
-
-$6.14 M(+161.5%)
-$12.77 M(+18.6%)
Dec 2020
-$10.76 M(+52.9%)
-$2.35 M(+20.2%)
-$10.76 M(+11.0%)
Sep 2020
-
-$1.95 M(-15.9%)
-$9.69 M(-12.5%)
Jun 2020
-
-$2.32 M(-43.8%)
-$11.09 M(+11.4%)
Mar 2020
-
-$4.14 M(+223.8%)
-$9.95 M(+41.4%)
Dec 2019
-$7.04 M
-$1.28 M(-61.8%)
-$7.04 M(+191.6%)
DateAnnualQuarterlyTTM
Sep 2019
-
-$3.35 M(+180.6%)
-$2.41 M(-28.0%)
Jun 2019
-
-$1.19 M(-2.6%)
-$3.35 M(-60.3%)
Mar 2019
-
-$1.22 M(-136.6%)
-$8.44 M(-41.6%)
Dec 2018
-$14.45 M(-46.3%)
$3.35 M(-178.1%)
-$14.45 M(-41.2%)
Sep 2018
-
-$4.28 M(-31.8%)
-$24.56 M(-10.9%)
Jun 2018
-
-$6.28 M(-13.2%)
-$27.57 M(-1.2%)
Mar 2018
-
-$7.24 M(+7.0%)
-$27.91 M(+3.8%)
Dec 2017
-$26.90 M(+143.6%)
-$6.76 M(-7.4%)
-$26.90 M(+13.2%)
Sep 2017
-
-$7.30 M(+10.3%)
-$23.76 M(+18.2%)
Jun 2017
-
-$6.62 M(+6.4%)
-$20.10 M(+32.1%)
Mar 2017
-
-$6.22 M(+71.8%)
-$15.21 M(+37.7%)
Dec 2016
-$11.04 M(+103.3%)
-$3.62 M(-0.3%)
-$11.04 M(+14.1%)
Sep 2016
-
-$3.63 M(+110.1%)
-$9.68 M(+27.2%)
Jun 2016
-
-$1.73 M(-15.9%)
-$7.60 M(+10.7%)
Mar 2016
-
-$2.06 M(-8.9%)
-$6.87 M(+26.4%)
Dec 2015
-$5.43 M(+2686.2%)
-$2.26 M(+44.4%)
-$5.43 M(+71.0%)
Sep 2015
-
-$1.56 M(+57.0%)
-$3.18 M(+96.7%)
Jun 2015
-
-$995.00 K(+60.5%)
-$1.61 M(+160.5%)
Mar 2015
-
-$620.00 K
-$620.00 K
Dec 2014
-$195.00 K
-
-

FAQ

  • What is NeuroBo Pharmaceuticals annual cash flow from operations?
  • What is the all time high annual CFO for NeuroBo Pharmaceuticals?
  • What is NeuroBo Pharmaceuticals annual CFO year-on-year change?
  • What is NeuroBo Pharmaceuticals quarterly cash flow from operations?
  • What is the all time high quarterly CFO for NeuroBo Pharmaceuticals?
  • What is NeuroBo Pharmaceuticals quarterly CFO year-on-year change?
  • What is NeuroBo Pharmaceuticals TTM cash flow from operations?
  • What is the all time high TTM CFO for NeuroBo Pharmaceuticals?
  • What is NeuroBo Pharmaceuticals TTM CFO year-on-year change?

What is NeuroBo Pharmaceuticals annual cash flow from operations?

The current annual CFO of NRBO is -$10.80 M

What is the all time high annual CFO for NeuroBo Pharmaceuticals?

NeuroBo Pharmaceuticals all-time high annual cash flow from operations is -$195.00 K

What is NeuroBo Pharmaceuticals annual CFO year-on-year change?

Over the past year, NRBO annual cash flow from operations has changed by +$913.00 K (+7.80%)

What is NeuroBo Pharmaceuticals quarterly cash flow from operations?

The current quarterly CFO of NRBO is -$5.59 M

What is the all time high quarterly CFO for NeuroBo Pharmaceuticals?

NeuroBo Pharmaceuticals all-time high quarterly cash flow from operations is $3.35 M

What is NeuroBo Pharmaceuticals quarterly CFO year-on-year change?

Over the past year, NRBO quarterly cash flow from operations has changed by -$2.20 M (-64.72%)

What is NeuroBo Pharmaceuticals TTM cash flow from operations?

The current TTM CFO of NRBO is -$22.68 M

What is the all time high TTM CFO for NeuroBo Pharmaceuticals?

NeuroBo Pharmaceuticals all-time high TTM cash flow from operations is -$620.00 K

What is NeuroBo Pharmaceuticals TTM CFO year-on-year change?

Over the past year, NRBO TTM cash flow from operations has changed by -$11.88 M (-109.97%)